Academic Journal

Clinical association between pharmacogenomics and adverse drug reactions

التفاصيل البيبلوغرافية
العنوان: Clinical association between pharmacogenomics and adverse drug reactions
المؤلفون: ZW Zhou, XW Chen, KB Sneed, YX Yang, X Zhang, ZX He, K Chow, T Yang, Wei Duan, SF Zhou
سنة النشر: 2015
مصطلحات موضوعية: Pharmacology and pharmaceutical sciences not elsewhere classified, School of Medicine, 111504 Pharmaceutical Sciences, 920102 Cancer and Related Disorders
الوصف: Adverse drug reactions (ADRs) are a major public health concern and cause significant patient morbidity and mortality. Pharmacogenomics is the study of how genetic polymorphisms affect an individual's response to pharmacotherapy at the level of a whole genome. This article updates our knowledge on how genetic polymorphisms of important genes alter the risk of ADR occurrence after an extensive literature search. To date, at least 244 pharmacogenes identified have been associated with ADRs of 176 clinically used drugs based on PharmGKB. At least 28 genes associated with the risk of ADRs have been listed by the Food and Drug Administration as pharmacogenomic biomarkers. With the availability of affordable and reliable testing tools, pharmacogenomics looks promising to predict, reduce, and minimize ADRs in selected populations.
نوع الوثيقة: article in journal/newspaper
اللغة: unknown
Relation: http://hdl.handle.net/10536/DRO/DU:30073291; https://figshare.com/articles/journal_contribution/Clinical_association_between_pharmacogenomics_and_adverse_drug_reactions/20908759
الاتاحة: http://hdl.handle.net/10536/DRO/DU:30073291
https://figshare.com/articles/journal_contribution/Clinical_association_between_pharmacogenomics_and_adverse_drug_reactions/20908759
Rights: All Rights Reserved
رقم الانضمام: edsbas.6CAD1732
قاعدة البيانات: BASE